Recently, a clinical GWAS with 1040 patients treated with paclitaxel identified 3 SNPs located in the EPHA5, FGD4 and NDRG1 genes that were associated with peripheral neuropathy[18]. The gene discussed is FGD4; the disease is peripheral neuropathy.